Cytocast

Cytocast

REVOLUTIONIZING DRUG DISCOVERY AND PERSONALIZED MEDICINE THROUGH CELL SIMULATION

Founded 2019 Hungary

Hungary 19 employees Pre-Seed Total: $1.86M Biotechnology, Health Care +3

Cytocast is a TechBio startup company founded in 2019, headquartered in Hungary. The company's slogan, "Safer and Smarter Drug Development - Transforming drug development and precision medicine with advanced cell simulation," reflects its mission to revolutionize drug development and precision medicine with its Cytocast Digital Twin platform. The platform integrates multi-omics data and advanced computational modeling to predict the effects of different drugs on cellular processes, enabling early-stage drug side effect predictions. Cytocast is at the forefront of advancing personalized medicine, moving towards tailored therapies with its advanced technologies. In May 2023, the company secured a €1.64M investment in a Pre-Seed Round from investors including Bonitas Venture Capital Fund, Zoiros Ventures, FastVentures, Futurmed, and KDT Holding. Cytocast's innovative approach and focus on patient well-being position it as a promising player in the Biotechnology, Health Care, Medical Devices, Pharmaceutical, and Clean Energy industries.

Funding Stage	Amount	Investors	Lead Investors	Date
Pre Seed Round	€1.64M	5	Bonitas Venture Capital Fund, Zoiros Ventures +3	15 May 2023
Pre Seed Round	€220.00K	1	Creative Accelerator	01 Dec 2021
Non Equity Assistance	Undisclosed	-		01 Jan 2020

Funding Stage

Amount

Investors

Lead Investors

Date

Pre Seed Round

€1.64M

Bonitas Venture Capital Fund, Zoiros Ventures +3

15 May 2023

Pre Seed Round

€220.00K

Creative Accelerator

01 Dec 2021

Non Equity Assistance

Undisclosed

01 Jan 2020

FAQ About Cytocast

REVOLUTIONIZING DRUG DISCOVERY AND PERSONALIZED MEDICINE THROUGH CELL SIMULATION

Cytocast was founded in 2019.

Cytocast is headquartered in Hungary.

Cytocast operates in Biotechnology, Health Care, Medical Devices, Pharmaceutical and Clean Energy. Its work centres on bioinformatics, drug discovery, personalized treatment and Budapest.

Cytocast has approximately 19 employees.

Cytocast has completed 3 funding rounds, raising a total of $1.86M. The latest funding stage is Pre-Seed.

Top alternatives and competitors to Cytocast include Celsius Therapeutics, SyntheticGestalt, Aster Insights, AIGEN Sciences Inc., Tyligand Bioscience. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Cytocast and Celsius Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About Cytocast

Funding Rounds & Investors (3)

Cytocast Alternatives & Competitors

FAQ About Cytocast